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Background: Asymptomatic Indian lacto vegetarians, who make up more than half of the Indian population in
different geographic regions, have distinctly low vitamin B-12 concentrations than non- vegetarians. Vegetarians
consume milk but it seems that the amount is not enough to improve vitamin B-12 status or vitamin B-12
concentration in milk itself may be low. The aim of this study was to determine if daily milk consumption can
improve vitamin B-12 status.
Methods: Fifteen male and 36 female, young healthy post-graduate volunteers participated. Blood from ten
participants (4 males and 6 females) was collected (day-1). They continued their regular diet for next fourteen days
and on day-15, blood of all 51 participants was collected, plasma vitamin B-12 concentration was measured and
were divided into two groups; Normal (vitamin B-12 >148 pmol/L, n = 22) and Vitamin B-12 deficient (<148 pmol/L,
n = 29), the remaining plasma was stored. All participants consumed 600 ml. of non-enriched buffalo milk (200 × 3)
during the day along with their usual diet. Next day blood was collected for plasma holotranscobalamin II
measurement. Subjects from deficient group continued to drink 400 ml of milk daily for next 14 days and blood
was collected on day-30. Plasma holotranscoabalamin II (day-1, 15, 16, 30), vitamin B-12, folate, total homocysteine,
creatinine and hematoloical parameters (day-1, 15, 30), and milk vitamin B-12 concentrations (day-15, 16, 30) were
measured.
Results: Fifty seven per cent of the participants were vitamin B-12 deficient and 65% were hyperhomocysteinemic.
No significant difference in biomarkers was observed when there was no intervention. Plasma holotranscobalamin II
concentration increased from 19.6 to 22.27 pmol/L (p < 0.0001) 24 hrs after milk load in the whole group. Plasma
vitamin B-12 increased from 92.5 to 122 pmol/L and tHcy concentrations decreased from 31.9 to 24.9 μ mol/L
(p < 0.0001 for both) 14 days after regular milk intake in vitamin B-12 deficient subjects.
Conclusions: Regular intake of milk improved vitamin B-12 status of vitamin B-12 deficient vegetarians indicating a
potential dietary strategy to improve the vitamin status.
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Dietary reference intake of vitamin B-12 was defined as
the amount required to prevent the overt vitamin B-12
deficiency that causes megaloblastic anemia and to
maintain plasma concentrations above 148 pmol/L [1].
The recommended dietary allowance (RDA) of vitamin
B-12 for adults in India is 1.0 μ g/day [2], whereas in* Correspondence: sadu_naik@rediffmail.com
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reproduction in any medium, provided the orUSA it is 2.4 μ g/day [3]. Vitamin B-12 intake by Indians
derives from natural food products, i.e. dairy products
viz. milk, yogurt, and cheese/butter, tea/coffee with milk
or from vitamin B-12 supplements. The relation be-
tween dietary intake and vitamin B-12 status has been
studied in different populations with conflicting results.
Howard et al [4] concluded that high frequency of
mildly abnormal cobalamin status in the elderly was not
due to poor intake of cobalamin, whereas, Framingham
Offspring [5] and Danish Study [6] showed significant
associations between dietary intake of vitamin B-12 and. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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study, Vogiatzoglou et al [7] found a significant associ-
ation between total daily dietary intake of vitamin B-12
and plasma vitamin B-12 concentrations. They further
stated that daily dietary intake of 6-10 μg of vitamin
B-12 ensured the maximum plasma vitamin B-12 con-
centration in persons with adequate vitamin B-12
absorption suggesting that the current RDA of 2.4 μ g/
day is also insufficient. The Framingham Offspring
Study [5] first observed that vitamin B-12 from milk
was better absorbed than meat. Wokes et al [8] system-
atically compared a group of US, Dutch and British
vegans with non-vegetarians from those same countries
and found that many of the vegans had significantly
lower vitamin B-12 concentrations than did non-
vegetarians. Dhopeshwarkar et al [9] showed that as-
ymptomatic Indian lacto vegetarians, who make up
more than half of the Indian population, have distinctly
low vitamin B-12 concentrations than non-vegetarians
which was confirmed by studies from different geo-
graphic regions of India [10-14]. Two main etiologic
factors play a role in developing vitamin B-12 defi-
ciency; inadequate dietary intake and/or vitamin B-12
mal-absorption.
Bhat et al [15] have used the rise in plasma holotrans-
cobalamin II ( holo-TC) concentrations with a smaller
dose of cyanocobalamin (6 μ g) in vitamin B-12 defi-
cient Indians as a marker of absorption. The increase in
plasma holo-TC concentration after vitamin B-12 load
provided experimental evidence that the increase was
due to recent vitamin B-12 absorption. The deficiency
of vitamin B-12 has been associated with diverse disor-
ders throughout the life span, from birth defects such
as shunted growth, neural tube defects, anemia to hy-
perhomocysteinemia and neuro-cognitive disorders in
adulthood [16-18]. Recently, low plasma vitamin B-12
concentrations in pregnancy have been shown to be as-
sociated with diminished neuro-cognitive performance
in offspring [19]. Several morbidities may be associated
with low-normal vitamin B-12 status (< 148 pmol/L).
Therefore, it is important to establish whether dietary
intervention by the available natural source can improve
vitamin B-12 status in Indian vegetarian population and
protect from diverse disorders.
The option of increasing overall vitamin B-12 status of
deficient population is either fortification or targeted
dietary recommendation. The present study measured
the effects of supplementation with 600 ml of skimmed
buffalo milk not enriched with vitamin B-12, during the
day on circulating holo-TC concentration. It also mea-
sured the supplementary effects with 400 ml of non-
enriched milk daily for 14 days on vitamin B-12 status
by measuring the changes in plasma holo-TC, vitamin
B-12 and total homocysteine (Hcy) concentrations.Subjects and methods
Participants
Young, healthy and post graduate students and staff
members of Deenanath Mangeshkar Hospital were in-
vited to visit the laboratory. They were told about the
high prevalence of vitamin B-12 deficiency in Indian
vegetarians and requested to participate in the inter-
vention study. Pregnant women, non-vegetarians and
lactose intolerant subjects were requested not to partici-
pate. Fifty one volunteers consented to participate in the
study (15 males and 36 females, day-0). They had no
clinical symptoms of vitamin B-12 deficiency and were
not taking vitamin B-12 supplementation or any drugs
known to influence vitamin B-12 absorption. All were veg-
etarians, non-smokers and none consumed alcohol. Their
milk intake was not more than 2 cups (120-140 mL) per
day. After recruitment, each participant was instructed to
report to the laboratory every day and give information
about their regular timely milk intake.
They were also instructed to not to change their life
style during the study period.
Study design
Intra-individual variation
Ten participants were selected for evaluating intra-
individual variation in the measurement of plasma vita-
min B-12, holo-TC, folate and tHcy concentrations.
They were instructed to not to change their life-style
during the study period. Their fasting blood was col-
lected in EDTA vacutainer on day-1 and day-15.
24-hrs. milk load test
Fasting blood of other 41 healthy participants was col-
lected in EDTA vacutainers on day-15. A portion of blood
was processed for hematological parameters within 30 -
minutes of collection and the rest was centrifuged at
1500 rpm for 20 minutes and the plasma was separated
and distributed in four storage vials and stored at -20°C.
All of them (51 participants) were instructed to drink
3×200 ml of milk along with their usual diet during the
day (in the morning after breakfast, evening at 4 p.m. and
at night after dinner) and come to the Laboratory next
morning-9 am. On day-16, 10 ml. of fasting blood was
collected and the separated plasma was stored as above
(Figure 1: Flow sheet).
Effect of daily milk intake on vitamin B-12 status
Plasma (day-15) vitamin B-12 was measured and the
participants were divided into two groups; normal group
(plasma vitamin B-12 > 148 pmol/L, n = 22) and the defi-
cient group (<148 pmol/L, n = 29). The participants from
the deficient group were instructed to drink 2×200 ml of
milk (in the morning after breakfast and after dinner)
every day along with their usual diet for the next 14 days
Flow Chart
Day 0 Participants registered (n=51)
(Dietary history)
Blood collection (Fasting) n=10 *
Day 1 Pl. vitamin B12, folate
Holo-TC, tHcy, hematology
Blood collection (Fasting)      
Day 15 Pl. vitamin B12, folate
Holo-TC, tHcy, hematology
(n=10*+41)
3 x 200 ml. of milk during the day 
Day 16 Blood Collection (fasting)      
Pl. holo-TC     (n=10*+41)
2 x 200 ml. of milk every day to participants who had 
Pl. vitamin B12 < 148 pmol/L x 14 days
Blood collection (Fasting), B12 deficient
Day 30 Hb, Pl. vitamin B12, folate
Holo-TC, tHcy ( n=29)
Figure 1 Flow chart: 51 Participants were registered on day-0.
Fasting blood was collected of 10 participants on day-1*. They were
instructed to continue their usual diet for next 14 days. On day-15
fasting blood was collected of all 51 participants. They consumed
3 × 200 ml of milk during the day. On day-16 fasting blood was
collected. They were divided into normal and vitamin B-12 deficient
groups as per pl. vitamin B-12 concentrations. Deficient participants
consumed 2 × 200 ml. milk every day for next 14 days and their
fasting blood was collected on day-30. Dietary history was taken on
day 1, 15, 30. Participant’s milk drinking time was in the morning
after breakfast, 4 p.m. and at night after dinner.
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blood was collected and processed as above. None of the
participants neither failed to drink milk nor omitted
(reported to the investigator on day-16, day-17 and then
every day morning till day-30). There was 100% compli-
ance in milk consumption from the participants. They
provided the sample (about 6 ml) of milk consumed for
measuring vitamin B-12 concentrations on day 15, 16
and 30 (Figure 1. Flow sheet).
Experimental procedure
Hematological parameters were measured on 5 part dif-
ferential cell counter (Sysmex, Cobe, Japan). Plasma
holo-TC concentration was measured using microparti-
cle enzyme immunoassay [20]. Microparticle enzyme
intrinsic factor assay was used for the quantitative deter-
mination of plasma vitamin B-12. Plasma folate and
tHcy were measured by fluorescent polarization immune
assay technique. Milk samples were incubated with de-
naturant (0.8 N sodium hydroxide solution with 0.005%
potassium cyanide) in 9:1 proportion for 15 minutes at
56°C, centrifuged and processed for vitamin B-12estimation after diluting with saline (1:10) as mentioned
for plasma. All the milk samples were processed for vita-
min B-12 measurements on the same day of collection.
These biomarkers were measured on Axsym System
(Abbott Laboratories, IL, USA). Plasma creatinine was
measured on Daytona (Randox, U.K.) using alkaline pic-
rate method [21]. The intra- and inter-assay coefficients
of variations were less than 6.2% for hematological and
biochemical (vitamin B-12, folate, holo TC, creatinine
and tHcy) parameters.
Dietary intake data
The participants were examined for gross clinical signs of
protein-energy under-nutrition and vitamin deficiencies
(vitamin A, B-complex, C and D). Staff enquired about
upper or lower gastro intestinal disease symptoms and
also about milk intolerance. They were interviewed re-
garding eating habits and health status before enrolling.
They consumed their habitual diet throughout the study.
Their dietary history (24 hr recall) was taken by trained
and experienced personnel at each visit (day-1, day-15,
day-30). 24 hr. diet recall questionnaire was administered
to record the portion size and quantity of consumption of
different foods which were rich in micronutrients at both
visits [22]. Foods rich in vitamin B-12 and folate were se-
lected and grouped into four groups; milk and milk
containing beverages, tea/coffee with milk, green leafy
vegetables and other vegetables. Vitamin B-12 and folate
intake were calculated using Dietsoft [23].
Ethics statement
The study was approved by the ethical committee of
Deenanath Mangeshkar Hospital & Research Centre,
Pune. Written informed consent was obtained from all
participants before enrolling into the study.
Dietary supplement
Vitamin B-12 concentrations in the milk samples from
12 different sources of non-enriched of milk (buffalo)
supply being consumed by the Pune population were
measured on three occasions (day-15, 16, 30).
Definitions
Folate and vitamin B-12 deficiency were defined as plasma
concentrations <2 ng/ml [24] and < 148 pmol/L [24] re-
spectively, hyperhomocysteinemia as plasma tHcy concen-
trations >15 μ mol/L [25], low holo-TC concentration as
<35 pmol/L [26], anemia as a hemoglobin concentration
<120 g/L in females and <130 g/L in males and macrocy-
tosis as mean corpuscular volume > 100 fL [27].
Statistical analysis
Intra individual variation was calculated from the estima-
tion of variance by ANOVA from the measurements of
Table 2 Contribution of vitamin B-12 from different food
groups in the participants





40 (30, 55) 0.18 (0.10, 0.22)
Milk (ml/d) 140 (120, 160) 0.56 (0.5, 1.03)
Yogurt (g/d) 70 (45, 120) 0.15 (0.06, 0.3)
Cheese/butter (g/d) 10 (9, 20) 0.1 (0.08, 0.18)
Median (25th centile, 75th centile).
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and day-15 before intervention.
The data is presented as median with 25th and 75th
percentiles. Differences between groups were tested
using Wilcoxon’s Signed rank matched pair test, a non
parametric test, for paired analysis. Association was
measured using Pearson Correlation Coefficient. Relative
percentage change was calculated with respect to pre-
supplementation value. The analysis was performed
using SPSS (version 12.0, Chicago, USA).
Results
The vitamin B-12 concentration in milk supplied by
the sources of Pune supply is shown in Table 1; ranges
from 2.50 to 3.85 μ g/L. There was no significant vari-
ation in vitamin B-12 content of the milk at different
times. Fifty one subjects (15 male and 36 female) partici-
pated in the study. Evaluating 24-hr recall questionnaire,
male subjects were consuming 1.1 μ g of vitamin B-12
per day while females 1.35 μg per day. Main dietary
sources of vitamin B-12 are listed in Table 2. Milk repre-
sented the predominant source of vitamin B-12 followed
by yogurt. Tea/coffee with milk also contributed to some
extent in these participants.
Vitamin B-12 intake was lower in deficient group
than the normal group (p = 0.02). Vitamin B-12 intake
was directly related to plasma vitamin B-12 and holo-TC
(r = 0.520 and 0.270 respectively, p = 0.001 for both) and
inversely to tHcy concentrations (r = -0.430, p = 0.001).
The relation was similar in both sexes. There was no folate
deficiency and the plasma folate concentrations wereTable 1 Vitamin B-12 concentration in the milk
(Sources of Pune supply)
Milk source Vitamin B-12 (μ g/L)
Day-15 Day-16 Day-30
Chitale (n = 30) 3.85(3.7,4.1) 4.0 (3.7,4.2) 3.9 (3.7,4.0)
n = 8
Rajhans (n = 3) 2.90, 3.1,2.9 2.8,2.8, 2.9 3.0, 3.2, 3.3
Katraj dairy (n = 3) 3.0, 3.2, 3.0 3.2, 3.0, 3.1 3.0, 2.8, 3.2
Godavari (n = 3) 2.95, 3.0. 3.1 3.3, 3.2, 3.0 3.3, 3.0, 3.3
Gowardhan (n = 1) 2.90 3.0 3.2
Bhaiya Rasta Peth (n = 1) 2.50 2.8 2.6
Sane dairy (n = 3) 2.7, 2.90, 3.0 3.1, 3.3, 3.0 3.2
Swarkar dairy (n = 3) 2.80, 3.1, 3.0 3.0, 3.3, 3.1 2.8, 3.2, 3.1
Amol milk (n = 1) 3.05 3.0 3.2
Baiya – Mundhwa (n = 3) 2.60, 2.8, 2.8 3.0, 2.8,3.0 3.0, 3.1, 2.8
Aarey milk (n = 1) 3.2 3.1 3.2
Someshwar dairy (n = 1) .8 3.0 3.0
The vitamin B-12 contents were similar throughout the study.
Median (25th, 75th centile).
n = number of participants consuming milk. Values are the vitamin B-12 concn.
in the milk.similar in both the groups. Calorie, protein and fat intake
were also similar and within the limits of Indian Council
of Medical Research recommendation [28] (Table 3).
The intra individual variation for holo-TC, vitamin B-12,
folate and tHcy were less than 6.2% for all, when there was
no intervention in their routine life style (Table 4). There
was no significant difference in vitamin B-12 intake at
different times (Table 1).
Hemoglobin, mean corpuscular volume, plasma creatin-
ine and tHcy were significantly higher in males (p < 0.001
for all). Plasma vitamin B-12 and holo-TC concentrations
were significantly higher in females (p < 0.001 for both).
Table 5 compares the extent of increase in plasma holo-
TC concentrations 24 hrs after the milk load (3 × 200 ml).
None of the participants complained of any sort of
discomfort and none suffered from diarrhea. The increase
in plasma holo-TC concentration 24 hrs after 600 ml milk
load, the median (range) increase as (%age and absolute),
was 25.8 (0-110%) and 4.2 (0-16.4) pmol/L (p < 0.01). 1/4th
of the participants showed less than 3.0 pmol/L (12.5%)
increase, half showed more than 26% and one fourth
showed more than 43% increase. The participants showing
less than 12.5% increase can be labeled as poor absorbers.
Percentage increase in plasma holo-TC concentration was
independent of basal holo-TC concentration (Figure 2).
The increase in plasma holo-TC concentration 15 days
after 400 ml milk intake every day, the median (range) in-
crease as (%age and absolute), was 35.1 (5.1-201%) and 5.0
(1-25.6 pmol/L). Similarly the decrease in plasma tHcy
concentration was 9.7(0.7-49.3%) and 6.9 (0.5-17 μmol/L)
respectively in vitamin B-12 deficient participants (p <
0.0001 for both). The significance was similar in both sexes.
We also divided the participants by the observed median
holo-TC concentration (22.7 pmol/L) and by <35 > pmol/L
(reference cutoff). Both interpret the significant increase in
plasma holo-TC 24 hr after milk load (Tables 6, 7).
Holo-TC: vitamin B-12 ratio. [Median (25th, 75%le)] on
day-15 of all participants was 0.11(0.08,0.16). Normal
participants showed 0.08 (0.07,0.12) and deficient showed
0.14 (0.0.09,0.17) on day-15 and 0.13 (0.010,0.18) on day
30. Deficient participants showed increased plasma holo-
TC but not significant.
Table 3 Dietary intake (24-hr recall) and basic biochemistry of the participants (normal & deficient)
All (n = 51) Normal (n = 22) Deficient (n = 29) p value
Age (years) 27.6(26,30) 29.0(27 – 31.0) 30.6 (28.5-32) ns
Male/female 14/37 4/18 10/19
Energy intake (calorie)/d 2240 (2080,2280) 2390 (2220,2480) 2200 (2080,2270) ns
Protein intake (g)/d 62 (52,80) 58 (50,82) 64 (55,80) ns
Fat (g/d) 45 (38,50) 44 (35,50) 43 (37,55) ns
Vitamin B-12 intake (μ g/day) 1.20 1.65 0.65 <0.02
(0.75,1.50) (1.4,1.85) (0.50,0.90)
Folate intake (μ g/day) 355 (320,400) 350.6 (310.4,415.4) 355.6 (318.2,425.4) ns
Hemoglobin (g/L) 127 (117,136) 124 (114,130) 128 (123,135) ns
Anemia% 14 14 14
Mean corpuscular volume (fL) 84.0 (81.0,90.5) 80.5 (75.0,85.0) 84.3 (82.2,90.4) ns
Plasma creatinine (mg/dL) 1.0 (0.9,1.1) 0.9 (0.8,1.1) 1.0 (0.9,1.1) ns
Plasma vitamin B-12*
(pmol/L)
130 (98,217) 244 (187,306) 92.8 (71,117) <0.0001
Plasma holo-TC (pmol/L)* 19.6 (13.1-31.1) 27.7 (19.8,42.5) 14.4 (10.82,19.75) <0.0001
Plasma folate (ng/mL) 6.24 (4.2,14.90) 6.6 (4.0,15.2) 5.6 (4.6,12.8) ns
Plasma tHcy ** (μ mol/L) 21.1 (12.7,32.7) 11.9 (10.4,15.0) 31.9 (22.6,54.0) <0.001
Median(25th, 75th centile) ns-non significant.
p- difference between normal group & deficient group.
* Vitamin B-12 intake is directly associated with pl. vitamin B-12 and holo-TC concentrations(r = 0.52 & 0.27, p < 0.001 for both) adjusting for sex.
** vitamin B-12 intake is inversely associated with pl. tHcy concentrations(r = - 0.43, p < 0.001).
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load in 4 normal and 2 deficient subjects. The basal
plasma holo-TC concentrations were more than 45
pmol/L and tHcy less than 12.5 μ mol/L in the normal
subjects in whom there was no rise in holo-TC concen-
trations. The two vitamin B-12 deficient participants did
not respond to the 24 hr milk intake. However, their
plasma vitamin B-12 (50, 105 pmol/L) increased to
(60,116), holo-TC (13.1, 19.4 pmol/L) increased to (14.9,
21.5) and tHcy (58.7, 32.8 μmol/L) decreased to (53.6,
28.1) respectively after 14 days of regular milk intake.Table 4 Effect of regular milk intake (14 days) on biomarkers
Milk intake 400 ml Deficient group
Every day n = 29
Day-15 Day-30
Hemoglobin (g/L) 128(123,135) 131(125,140)
Mean corpuscular
volume (fL)
84.3 (82.2,90.4) 86.2 (83.5,91.0)
Creatinine (mg/dL) 1.0 (0.9,1.1) 0.9(0.85,1.1)
Pl. vitamin B-12
(pmol/L)
92.8 (71.0,117.6) 122.1 (90.6,141.3)
Pl. folate (ng/mL) 5.6 (4.6, 12.8) 5.7 (4.6, 11.9)
Pl. holo-TC (pmol/L) 14.4 (10.82, 19.75) 19.2 14.95,24.6)
Pl. tHcy (μ mol/L) 31.9 (22.6,54.0) 24.9 (18.54,41.45)
p-values by Wilcoxon’s Signed rank test, a non-parametric test for paired analysis nThere was no significant difference in hemoglobin, MCV,
plasma creatinine and folate concentrations in vitamin
B-12 deficient participants 14 days after regular intake of
milk, whereas, the increase in plasma vitamin B-12, holo-
TC and the decrease in plasma tHcy concentration was sig-
nificant (p < 0.0001 for all), Table 4. There was no gender
difference in the improvement of vitamin B-12 status.
Basal hemoglobin was not associated with circulating
vitamin B-12 concentration. However, mean corpuscular
volume was inversely related to plasma vitamin B-12.






<0.0001 115.5 (97.7, 177.6) 113.9 (102.1, 173.2)
ns 6.1 (4.4, 13.8) 5.9 (4.2, 14.9)
<0.0001 19.2(10.2,23.5) 19.5(11.1,22.9)
<0.0001 22.85 (20.5,35.7) 23.9 (20.7,31.7)
s- not significant. Median (25th, 75th %le).
Table 5 Effect of milk load (600 ml) on plasma holo-TC concentrations
All (n = 51) Normal group (n = 22) Deficient group (n = 29)
Day-15 Day-16 * Day-15 Day-16 N.S. Day-15 Day-16 ***
Plasma holo-TC concn. 19.6 22.27 27.7 31.3 14.4 18.3
(pmol/L) (13.1,31.1) (16.6,35.8) (19.8,42.5) (21.6,46.1) (10.8,19.7) (13.7,25.2)
Values are Median (25th, 75th centile). p-values by Wilcoxon’s Signed rank test, a non- parametric test for paired analysis (* p <0.01, *** p < 0.0001,
N.S.- not significant).
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with holo-TC, vitamin B-12 and tHcy concentrations.
Discussion
The present study is to determine the beneficial effect of
regular consumption of adequate milk on vitamin B-12
status in predominantly young vitamin B-12 deficient
vegetarian Indians who had no folate deficiency. Milk
was only found to be a significant contributor to vitamin
B-12 intake in these participants.
Fifty seven percent of the participants had vitamin
B-12 deficiency and 65% had hyperhomocysteinemia,
84% had low plasma holo-TC (<35 pmol/L) concentra-
tions. However, none had any clinical (neurological/
anemia) symptoms of vitamin B-12 deficiency. They
could be termed as subjects with Sub Clinical Cobalamin
deficiency. One half of the participants with normal
vitamin B-12 status (plasma vitamin B-12 >148 pmol/L
and tHcy <15 μ mol/L) had lower plasma holo-TCPl. vitamin B-12 <148 pmol/L R2 Linear=0.263
Pl. vitamin B-12 >148 pmol/L R2 Linear=0.383
Figure 2 Percentage increase in plasma holo-TC concentration
in participants 24hr after 600 ml of milk load from base
line (day-15).concentrations (median 27.7 pmol/L) than normal white
Caucasians [5,6,29,30]. The participants were consuming
less than 1.4 μ g vitamin B-12 in daily diet. There was a
significant association between dietary intake of vitamin
B-12 and plasma vitamin B-12 and holo-TC concentra-
tions which is in agreement with other studies [5,7,29].
Holo-TC has a short half-life [31,32] and is therefore
proposed to reflect recent vitamin B-12 absorption.
Once in circulation, holo-TC is taken up into cells
within minutes [33,34]. Until the cells are saturated with
holo-TC, most of it is taken up so quickly that no large
changes are observed initially in blood. Significant
changes in the plasma holo-TC concentrations can be
measured when the intake of vitamin B-12 is sufficient
to saturate the cells with vitamin B-12. A dose depen-
dent Holo-TC rise during 24 hrs following vitamin B-12
administration suggested that the levels are influenced
by recent absorption [15]. Plasma holo-TC concentration
significantly increased (0-120%, p = 0.0001) in vitamin
B-12 deficient participants 24 hrs. following the milk
load (Figure 2). Bhat et al [15] found a significant in-
crease in plasma holo-TC concentration (0-150%) 24 hrs
after loading with 6 μg of cyanocobalamin in vitamin
B-12 deficient subjects while Bor et al [35] found an
increase (0-108%) in normal subjects after 27 μg load.
Bor et al [35] and Castel-Roberts et al [36] reported that
measuring the rise in plasma holo-TC concentration
24 hrs after vitamin B-12 load is better to assess recent
intestinal absorption than measuring plasma vitamin
B-12 alone. One fourth of the participants showed
<12.5% increase in holo-TC concentration after milk
load. They may have mal-absorption or the ingested
vitamin B-12 may have been used to saturate the cells.
However, their plasma tHcy was reduced in vitamin
B-12 deficient participants. These subjects need further
evaluation for their gastrointestinal absorption status.
Whereas, the participants with normal plasma B-12 con-
centration who did not show any increase in plasma
holo-TC concentrations had basal level of >45 pmol/L
with <12.5 μ mol/L of plasma tHcy which implies that
plasma holo-TC concentration reaches a plateau when
basal plasma holo-TC concentration exceeds 45 pmol/L
in vitamin B-12 deficients, similar to the observation by
Bhat et al [15] who reported that plasma Holo-TC con-
centration increased from 10.6 pmol/L to 24.9 in adult
Indian males and 30.5 pmol/L in females after ingesting
Table 6 Plasma holo-TC increase considering the cutoff for holo-TC as 35 pmol/L(reference cutoff)
All participants
n = 51
Pl. holo-TC > 35pmol/L
(med vit B-12 267 pmol/L)
n = 11
Pl. holo-TC < 35pmol/L
(med vit B-12 155 pmol/L)
n = 40
Pl. holo-TC pmol/L Day-15 Day-16 P = 0.001 Day-15 Day-16 P = 0.013 Day-15 Day-16 P < 0.0001
19.6 (13.1,31.1) 22.27 (16.6,35.8) 42.7 (36.2,61.9) 47.2 (44.1,60.7) 18.4 (16.6,22.0) 20.45 (15.6,29.1)
Median (25th, 75th centile).
p-compared to day-15 concentration.
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9.7 to 47.5 pmol/L in females after 30 μ g of cyano-
cobalamin ingestion.
Regular consumption of milk for 14 days increased the
circulating concentration of vitamin B-12, holo-TC and
decreased tHcy concentration in vitamin B-12 deficient
participants indicating efficient metabolic effects (Table 4).
Carmel [37] categorized available biomarkers as those
that directly measured plasma vitamin B-12 and those
that measured metabolites that accumulated with inad-
equate amounts of vitamin B-12. Serum holo-TC and
vitamin B-12 measured circulating vitamin B-12 concen-
trations. These two therefore reflected the broad vitamin
B-12 status from high risk of severe deficiency to ad-
equacy. Miller et al [38] stated that holo-TC and total vita-
min B-12 have equal diagnostic accuracy in screening for
metabolic vitamin B-12 deficiency. Measurement of both
holo-TC and total vitamin B-12 provided a better screen
for vitamin B-12 deficiency than either assay alone.
According to Green [39], low vitamin B-12 status was
indicated by being below the lower the reference range
(for vitamin B-12 < 148 pmol/L; for holo TC, <35 pmol/L),
whereas for indirect measures of metabolites (methylma-
lonic acid or homocysteine), low vitamin B-12 status mea-
sures would be indicated by a level above the upper limit of
the reference range (for methylmalonic acid, >260 nmol/L;
for homocysteine, >12 μmol/L). The markers he mentioned
were homocysteine for detection of either vitamin B-12 or
folate deficiency and methylmalonic acid for vitamin B-12
deficiency only.
However, Valente et al [40] suggested a diagnostic
strategy using holo-TC as the front-line test. The cutoffs
for deficiency were defined as 20 pmol/L for holo-TCTable 7 Plasma holo-TC increase considering the cutoff
for holo-TC as median obtained in the present study
(22.7 pmol/L)
Pl. holo-TC > 22.7pmol/L
(med vit B-12 280 pmol/L)
n = 19
Pl. holo-TC < 22.7pmol/L
(med vit B-12 139 pmol/L)
n = 32
Day-15 Day-16 P = 0.002 Day-15 Day-16 P < 0.0001
36.5 (33.1,43.1) 45.5 (35.8,50.6) 14.7 (11.1,19.2) 18.5 (14.1,23.1)
median (25th, 75th centile).
p-compared to day-a5 concentration.and 123 pmol/L for serum vitamin B-12 after studying
employees and medical students of a local hospital
at Dundee, UK. We defined the participants as vitamin
B-12 deficient who showed <148 pmol/L of plasma vita-
min B-12 concentration.
Yajnik et al [41] observed that the habitual intake of
green leafy vegetables or other vegetables did not affect
plasma vitamin B-12 or tHcy concentrations. They [41]
have reported that the oral vitamin B-12 supplementa-
tion reduced plasma tHcy concentration in first two
weeks but did not achieve normal plasma tHcy concen-
trations even after 6 wks. Deshmukh et al [42] studied
the effects of physiological doses of oral vitamin B-12 on
plasma tHcy and observed that the reduction was 5.5
and 6.8 μ mol/L after 4 and 12 months of 2 μ g supple-
mentation per day respectively, while supplementation
of 10 ug per day for 6 and 12 months reduced plasma
tHcy concentration by 5.6 and 6.9 μ mol/L respectively.
There was no advantage in supplementing with higher
dose. It has been observed in healthy adults that about
50% of a 1-μg dose of vitamin B-12 is absorbed from
food, while only 20% of a 5 μ g dose, and 5% of a 25 μ g
dose is absorbed [43]. Therefore, intervention with at
least 1.0 to 1.54 μ g of additional vitamin B-12 available
from milk every day producing beneficial metabolic ef-
fect, increasing plasma vitamin B-12 and reducing tHcy,
is advocated.
The novelty of the present study is that it used milk sup-
plementation to measure both absorption capacity and
efficiency to reduce plasma tHcy levels. Bor et al [35], von
Castel-Roberts et al [36] and Bhat et al [15], used free
cyanocobalamin to assess intestinal vitamin B-12 absorp-
tion while Deshmukh et al [43] used free cyanocobalamin
for lowering plasma homocysteine levels. Although cyano-
cobalamin increases circulating levels of cobalamin, its
ability to increase tissue levels of the active form of vita-
min B-12 can be limited in a large number of subclinical
and clinical conditions. The activation of cyanocobalamin
to either adenosyl cobalamin or methyl cobalamin does
not occur instantly, possibly occurring over 1-2 months
[44] and requires decyanation, interaction of glutathione
and in the case of methyl cobalamin, S-adenosyl methio-
nine and the active form of folic acid. Qubeck study
conducted on pigs showed that the intestinal absorption
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synthetic form of vitamin B-12 by comparing the net
fluxes of vitamin B-12 across the portal drained viscera
after ingestion of milk or synthetic vitamin B-12 [45].
Vitamin B-12 in milk is in the form of coenzyme (adenosyl
cobalamin), a major form in cellular tissues, where it is
retained in the mitochondria, facilitating faster metabolic
actions [46].
Even though the increase in plasma vitamin B-12 concen-
trations was modest (29.6 pmol/L) following milk intake by
the participants, such an increase would be beneficial in
vitamin B-12 deficient subjects. The increase in plasma
holo-TC concentration after regular milk intake helped in
lowering plasma tHcy concentrations (by 7 μmol/L).
The limitation of the present study is that we have not
measured plasma methylmalonic acid concentration which
is a specific biomarker for vitamin B-12 deficiency status.
The other marker, tHcy gets accumulated in both vitamin
B-12 and folate deficiency. However, none of our partici-
pants had folate deficiency. The participants with >148
pmol/L of plasma vitamin B-12 concentrations were not
studied after 14 days consuming 400 ml milk every day.
The recommended dietary allowance (1 μg/day) for
Indians seems to be inadequate. Even though there was
significant reduction in plasma tHcy concentration 14 days
after providing regular dietary vitamin B-12 (2.5 to 3 μg)
in the form dairy products, the levels did not reach to
normal levels. Effect of long term daily intake of milk on
vitamin B-12 status should form a part of future study.
Conclusions
In conclusion, the present study reveals that dairy foods
provide a highly bio-available source of vitamin B-12.
Plasma holo-TC concentration increase 24 hrs after milk
load can be a marker for dietary vitamin B-12 absorption
ability. Adequate milk intake has the potential to increase
circulating vitamin B-12 and holo-TC concentrations and
reduce tHcy concentrations, a risk factor for cardio-
vascular disease. This study has implications for guidelines
for the maintenance of normal vitamin B-12 status. Further
study on large number of subjects with long term advice to
consume adequate milk and observe the beneficial effects
on health due to the improvement in vitamin B-12 status is
needed. Then promotion of an adequate milk intake would
be a good therapeutic strategy.
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